| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.58 | 0.05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |